Methylation of the MAOA promoter is associated with schizophrenia.

Yang H, Li J, Ji A, Hu L, Zhang X, Liu L, Qing L, Yan M, Nie S

DOI: 10.21037/atm-20-4481
Published: 2020 Jul
Container: Annals of translational medicine
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.21037/atm-20-4481,
  title = {Methylation of the MAOA promoter is associated with schizophrenia.},
  author = {Yang H and Li J and Ji A and Hu L and Zhang X and Liu L and Qing L and Yan M and Nie S},
  year = {2020},
  journal = {Annals of translational medicine},
  doi = {10.21037/atm-20-4481},
  url = {https://doi.org/10.21037/atm-20-4481}
}

RIS

TY  - JOUR
TI  - Methylation of the MAOA promoter is associated with schizophrenia.
AU  - Yang H
AU  - Li J
AU  - Ji A
AU  - Hu L
AU  - Zhang X
AU  - Liu L
AU  - Qing L
AU  - Yan M
AU  - Nie S
PY  - 2020
JO  - Annals of translational medicine
DO  - 10.21037/atm-20-4481
UR  - https://doi.org/10.21037/atm-20-4481
ER  -

APA

H, Y., J, L., A, J., L, H., X, Z., L, L., L, Q., M, Y., & S, N. (2020). Methylation of the MAOA promoter is associated with schizophrenia.. Annals of translational medicine. https://doi.org/10.21037/atm-20-4481

Source records

pubmed · retrieved 2026-09-25T04:17:25.815Z